ArcherDX launches Immune Repertoire Sequencing Assays at ASH 2016
Point-EXACCT transformation from microtiterplate to microarray
Frontiers | Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing
Archer FusionPlex Oncology Research
Next-Generation Sequencing (NGS) | OncologyPRO
Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation | Business Wire
Archer FusionPlex Oncology Research
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology - ScienceDirect
Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics | BMC Medical Genomics | Full Text
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches | Scientific Reports